Triple-negative breast cancer (TNBC) is a subtype of breast cancer characterized by the absence of hormone receptors (estrogen receptors (ERs) and progesterone receptors (PRs)) and human epidermal growth factor receptor 2 (HER2). This evidence concerns the gene ERBB2 and triple-negative breast carcinoma.